Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program ...

Vertex Pharma to Submit Kidney-Disease Drug Application to FDA by Year-End

As part of the FDA's rolling review of the biologics license application, Vertex expects to submit the first module to the regulator for potential accelerated approval before the end of 2025, and said ...
TipRanks on MSN

Vertex Pharmaceuticals announces updates across program for povetacicept

Vertex Pharmaceuticals (VRTX) announced several important updates across its development program for povetacicept, an investigational recombinant ...

Adtalem, Google Cloud to launch AI credential program for healthcare professionals

Adtalem Global Education said on Wednesday it will partner with Alphabet's Google Cloud to launch an artificial intelligence ...

Vertex Achieves Oracle Validated Integration for Delivering a Proven, Repeatable Integration for Oracle’s ERP Solution

To achieve Oracle Validated Integration, partners such as Vertex demonstrate their integrated offering aligns with Oracle integration best practices and performs as documented.
TMCnet

Oracle Database@Google Cloud Adds New Oracle AI Database Services, Additional Regions, and Groundbreaking Partner Program

Oracle and Google Cloud today announced enhancements to Oracle Database@Google Cloud that provide customers with more ways to leverage the powerful multicloud database service to innovate faster and ...

4 Healthcare Stocks to Buy Now

As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.